Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price
Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price buy - large image1
Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price buy - image1
Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price buy - image2
Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price buy - image3
Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price buy - image4
Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price buy - image5
Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price buy - image6

Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price

6765 Inquiries

Unit Price:

$90-110/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99.9%

Port:

Shanghai

Brand:

JY

Packaging:

10mg/vail,10vails/box

Price valid (until):

2026-12-20

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


       Product Detail   



    Retatrutide (LY3437943) acetate is a triple agonist peptide for the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).

    Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively. It exhibits activity on mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191, and 0.794 nM, respectively.

    In vivo, Retatrutide (LY3437943) acetate engages with GCGR and enhances glucose tolerance in an ipGTT by acting through GIP or GLP-1 receptors. Activation via the glucagon receptor by Retatrutide acetate leads to significant weight reduction and increased energy expenditure. Retatrutide acetate can be utilized in research related to obesity.

    Retatrutide achieves comprehensive metabolic regulation through triple receptor activation:

    ※ GLP-1R:  Slows gastric emptying, enhances satiety, and reduces appetite.

    ※ GIPR:  Regulates hunger signals in the central nervous system, further suppresses appetite and improves energy metabolism.

    ※ GCGR:  Promotes glucagon secretion, accelerates fat and glycogenolysis, and increases basal metabolic rate.

    CAS: 2381089-83-2

    Molecular Formula: C221H342N46O68

    Molecular Weight: 4731.33

    Sequence: H-Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

    Appearance: White Powder

    Purity (HPLC): ≥99.0%

    Single Impurity (HPLC): ≤1.0%

    Sodium Content (HPLC): 5.0%-12.0%

    Moisture Content (Karl Fischer): ≤10.0%

    Peptide Content: ≥80.0%

    Storage: Store at 2-8 degrees Celsius in a dry and cool place.

    Packaging: 1g-1kg, plastic bottle

    Intended Use: For scientific research purposes


    Clinical data

    Other names

    LY-3437943

    Identifiers

    CAS Number

    UNII

    • NOP2Y096GV

    ChEMBL

    • ChEMBL5095485

    Chemical and physical data

    Formula

    C223H343F3N46O70

    Molar mass

    4845.444 g·mol −1


      Product Pictures 


    Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 1 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 2 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 3 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 4 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 5 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 6

    Factory Pictures

    Connect With:Domi

    WhatsApp:+86 18331965818

    Email: domi@xtjytech.com

    Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 7  Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 8 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 9 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 10

    Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 11


       Product Function


    Indications and Efficacy:

     Obesity Treatment:
    In the Phase II clinical trial, patients in the highest dose group (12 mg) lost an average of 24.2% weight after 48 weeks, and some patients lost more than 30%.

     Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD):
    Retatrutide can reduce liver fat content by 86%, and more than 85% of patients achieve regression of liver steatosis.

     Type 2 Diabetes:
    Significantly reduce glycated hemoglobin (HbA1c) and improve blood sugar control.

     Potential Cardiovascular Benefits:
    Animal studies have shown that it may indirectly protect cardiovascular health by improving blood pressure and heart function, but further clinical verification is needed.

    Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 12 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 13



      Modes Of Transport  


    Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 14


      Payment Methods   


    Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 15


     FAQ  


    Q: How to store it?

    A: If it hasn't been opened, just put it in cool dry place, if it is opened, you may put it in cold storage for 2-5 degree condition.

    Q: How to order this product?

    A: You can click "contact Supplier" , or write an email to my inbox, and send us a inquiry, leave your number if possible, we will contact with you as soon as possible, then we can talk order details.

    Q: How about the delivery time?

    A: Shipped within 48 hours after payment is received.Small orders are shipped via express door-to-door.The goods arrive in about7-10 days.

    Q :  ls cash on delivery ?

    A:in most cases,we don't support cash on delivery.

    Q: How much is the commodity?

    A: As we all know, the price of chemicals is not fixed, but fluctuates with the market.

    You need to contact me to get the latest product price, we promise to give you the most favorable price.

    Q:About the after-sale service?

    A:After purchasing the products from our Company, we have a professional technical team and after-sales team to serve you and solve all your problems in the future.


      Company Details 


    About us

    Xingtai Junyi Peptides Technology Co.,Ltd is a leading and dedicated pharmaceutical distributor committed to improving patient outcomes by facilitating access to innovative and life-changing medications. We specialize in the reliable, compliant, and efficient sourcing and distribution of high-demand therapeutics, with a core focus on patide.

    Our Mission
    Our mission is to bridge the gap between cutting-edge pharmaceutical innovation and the healthcare providers and patients who need it most. We achieve this by ensuring a seamless, secure, and transparent supply chain for critical medications like Retatrutide, adhering to the highest standards of quality, regulatory compliance, and ethical business practices.

    Core Focus: patide Expertise
    Patide represents a significant advancement in metabolic disease treatment. As specialists in this vital medication, we offer:
    Reliable Supply:We maintain robust partnerships and supply chain networks to ensure consistent availability of genuine Retatrutide.
    Regulatory Compliance:We operate with strict adherence to all national and international regulations governing the pharmaceutical trade, including licensing, cold chain management (where applicable), and documentation.
    Quality Assurance: We guarantee the authenticity and integrity of our products, sourcing only from authorized and vetted channels. Quality control is paramount at every stage.
    Market Knowledge:Our team possesses deep expertise in the Retatrutide market, its indications, and the evolving needs of healthcare providers and payers.
    Efficient Distribution:We leverage optimized logistics to deliver Retatrutide safely and promptly to pharmacies, hospitals, clinics, and authorized healthcare facilities.

    Who We Serve: We partner with:
    Pharmacies (Retail, Hospital, Specialty): Providing a dependable source for fulfilling patient prescriptions.
    Hospitals and Healthcare Systems: Supporting formularies and patient care protocols requiring Retatrutide.
    Wholesalers & Distributors: Acting as a key supplier within the pharmaceutical supply chain.
    Authorized Healthcare Providers:Facilitating access for clinics and practices treating eligible patients.

    Our Commitment:
    Patient-Centricity: Ultimately, our work enables better patient access to transformative therapies like Retatrutide.
    Integrity: We conduct business with transparency, honesty, and unwavering ethical standards.
    Partnership: We strive to build long-term, collaborative relationships based on trust and mutual success with our clients.
    Excellence: Continuous improvement in our processes and services is fundamental to our operations.

    Why Partner With Us for patide?
    Choose Xingtai Junyi Peptides Technology Co.,Ltd  for your patide supply needs and benefit from our specialized focus, proven reliability, stringent compliance, and commitment to excellence. We are more than a distributor; we are a dedicated partner in advancing metabolic health.

    Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 16 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 17  Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 18 Shop Retatrutide,loss weight,2381089-83-2,LY3437943;Safe Transportation;High Quality and High Purity;Wholesale and Suitable Price-Detailed Image 19

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide

    Location:

    Room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    3

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Certifications:

    DNV,CQC,GMP,SGS

    Xingtai Junyi Technology Co.,Ltd. Was established in 2019. It mainly deals in peptide products, synthetic peptide amino acids, beauty and slimming products, and beauty freckle removal cosmetic raw materials. It has strong R&D capabilities, superb synthesis technology, and advanced quality control methods. It effectively promotes joint ventures with major companies and manufacturers, and serves the society and users with the concept of industrial development. It always adheres to market demand-oriented, continuously synthesizing new high-tech freckle and wrinkle removal beauty peptide products, which are mainly exported to the United States, Europe, South Africa, Nigeria and other countries and regions. It has rich export experience and ensures transportation safety.

  • Inquiry History
    6765 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.